KRT8 anticorps (C-Term)
Aperçu rapide pour KRT8 anticorps (C-Term) (ABIN6262789)
Antigène
Voir toutes KRT8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Cytokeratin 8 Antibody detects endogenous levels of total Cytokeratin 8.
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human Cytokeratin 8, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Date de péremption
- 12 months
-
-
- KRT8 (Keratin 8 (KRT8))
-
Autre désignation
- KRT8
-
Sujet
-
Description: Together with KRT19, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Gene: KRT8
-
Poids moléculaire
- 53kDa
-
ID gène
- 3856
-
UniProt
- P05787
Antigène
-